Lavori attuali relativi a Vp, Head Translational Research, Vaccines - Siena - 9627 Corixa Corporation


  • Siena, Italia GSK A tempo pieno

    Site Name: USA - Massachusetts - Cambridge, Belgium-Wavre, Italy - Siena, UK - Hertfordshire - Stevenage, UK - London, USA - Pennsylvania - Upper Providence Posted Date: Jan VP, Head Translational Research Vaccines & Infectious Diseases Research Unit, R&D Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5...


  • Siena, Italia GSK A tempo pieno

    Site Name: USA - Massachusetts - Cambridge, Belgium-Wavre, Italy - Siena, UK - Hertfordshire - Stevenage, UK - London, USA - Pennsylvania - Upper Providence Posted Date: Jan VP, Head Translational Research Vaccines & Infectious Diseases Research Unit, R&D Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5...


  • siena, Italia GSK A tempo pieno

    Site Name: USA - Massachusetts - Cambridge, Belgium-Wavre, Italy - Siena, UK - Hertfordshire - Stevenage, UK - London, USA - Pennsylvania - Upper ProvidencePosted Date: Jan VP, Head Translational ResearchVaccines & Infectious Diseases Research Unit, R&DIntroductionAt GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5...


  • Siena, Italia GSK A tempo pieno

    Site Name: USA - Massachusetts - Cambridge, Belgium-Wavre, Italy - Siena, UK - Hertfordshire - Stevenage, UK - London, USA - Pennsylvania - Upper Providence Posted Date: Jan VP, Head Translational Research Vaccines & Infectious Diseases Research Unit, R&D Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5...


  • siena, Italia GSK A tempo pieno

    Site Name: USA - Massachusetts - Cambridge, Belgium-Wavre, Italy - Siena, UK - Hertfordshire - Stevenage, UK - London, USA - Pennsylvania - Upper ProvidencePosted Date: Jan VP, Head Translational ResearchVaccines & Infectious Diseases Research Unit, R&DIntroductionAt GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5...


  • Siena, Italia GSK A tempo pieno

    A leading biopharma company in Siena is seeking a VP, Head of Translational Research to lead innovative vaccine research initiatives. You will manage a global team, engage with diverse research functions, and drive operational execution of clinical study data. The ideal candidate holds a PhD and has extensive leadership experience in vaccine research, with a...


  • Siena, Italia GSK A tempo pieno

    A leading biopharma company in Siena is seeking a VP, Head of Translational Research to lead innovative vaccine research initiatives. You will manage a global team, engage with diverse research functions, and drive operational execution of clinical study data. The ideal candidate holds a PhD and has extensive leadership experience in vaccine research, with a...


  • Siena, Italia GSK A tempo pieno

    A global biopharma company is seeking a Head of Vaccines for Global Health in Siena, Italy. This leadership role focuses on advancing affordable vaccines through innovative technologies and dynamic research. Responsibilities include scientific direction, cross-functional team leadership, and strategic planning for global health impact. Ideal candidates...

  • Head of Adjuvants

    2 settimane fa


    Siena, Italia GlaxoSmithKline A tempo pieno

    **Head of Adjuvant & Delivery Systems** At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK...


  • Siena, Italia GSK A tempo pieno

    **Site Name**: Italy - Siena **Posted Date**: Jul 8 2025 At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people over the next 10 years. R&D is committed to discovering and delivering transformational vaccines and medicines to prevent and change the course of disease. Science and technology are coming...

Vp, Head Translational Research, Vaccines

3 ore fa


Siena, Italia 9627 Corixa Corporation A tempo pieno

VP, Head Translational Research Vaccines Waltham, MA; Rockville, MD; or San Francisco, CA, the annual base salary for new hires in this position ranges $309,000 to $515,000.The US salary ranges take into account a number of factors including work location within the US market, the candidate's skills, experience, education level and the market rate for the role.In addition, this position offers an annual bonus and eligibility to participate in our share based long term incentive program which is dependent on the level of the role.Available benefits include health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and paid caregiver/parental and medical leave.If salary ranges are not displayed in the job posting for a specific country, the relevant compensation will be discussed during the recruitment process.Please visit to learn more about the comprehensive benefits program GSK offers US employees.Why GSK?Uniting science, technology and talent to get ahead of disease together.GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines.We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.People and patients around the world count on the medicines and vaccines we make, so we're committed to creating an environment where our people can thrive and focus on what matters most.Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.